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ABSTRACT 
Midbrain dopaminergic (mDA) neurons degenerate in Parkinson’s disease and are one of the main 
targets for cell replacement therapies. However, a comprehensive view of the signals and cell types 
contributing to mDA neurogenesis is not yet available. By analyzing the transcriptome of the mouse 
ventral midbrain at a tissue and single-cell level during mDA neurogenesis we found that three 
recently identified radial glia types 1-3 (Rgl1-3) contribute to different key aspects of mDA 
neurogenesis. While Rgl3 expressed most extracellular matrix components and multiple ligands for 
various pathways controlling mDA neuron development, such as Wnt and Shh, Rgl1-2 expressed 
most receptors. Moreover, we found that specific transcription factor networks explain the 
transcriptome and suggest a function for each individual radial glia. A network controlling 
neurogenesis was found in Rgl1, progenitor maintenance in Rgl2 and the secretion of factors 
forming the mDA niche by Rgl3. Our results thus uncover a broad repertoire of developmental 
signals expressed by each midbrain cell type during mDA neurogenesis. Cells identified for their 
emerging importance are Rgl3, a niche cell type, and Rgl1, a neurogenic progenitor that expresses 
ARNTL, a transcription factor that we find is required for mDA neurogenesis. 
  
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/155846doi: bioRxiv preprint first posted online Jun. 26, 2017; 
3 
 
INTRODUCTION 
Our knowledge of the contribution of individual signals to midbrain dopaminergic (mDA) 
neuron development has grown in a considerable manner in recent years. It is currently thought that 
the development of mDA neurons is controlled by the interaction of multiple transcription factors 
and signaling pathways (Arenas et al, 2015; Smidt & Burbach, 2007). However, we still lack the 
systematic knowledge required to understand how all these factors are coordinated over time and 
space, in the complex signaling microenvironments in which the cells reside. These 
microenvironments, referred to as niches, consist of an extracellular matrix (ECM) and local 
paracrine/autocrine signals contributed by neighboring cells (Jones & Wagers, 2008). Far from 
static, such microenvironments are constantly being remodeled (Scadden, 2006; Jones & Wagers, 
2008), leading to progressive changes in composition over time, which control fundamental 
developmental processes such as cell fate or the balance between proliferation and neurogenesis (Lu 
et al, 2011). In the nervous system, some of the critical cell types controlling neural development 
are radial glia cells. Typically, radial glia (Rgl) cells are bipolar cells with their somas located in the 
ventricular zone (VZ) and their processes extending to the ventricular cavity and radially to the pial 
surface. These cells, once thought to be a scaffold for neurogenesis, are currently thought to be 
transient stem cells, capable of limited self-renewal, of giving rise to different cell lineages and of 
undergoing neurogenesis by asymmetrical cell division (Götz & Huttner, 2005; Taverna et al, 
2014). In the developing VM, it is unknown how many cells contribute to the DA neurogenic niche, 
how they contribute to neurogenesis, what factors do they express and what are the transcriptional 
networks operating in each of these cells. We previously reported that a proliferative floor plate Rgl 
cell gives rise to mDA neurons through the generation of a lineage with subsequent cellular 
intermediates (Bonilla et al, 2008). However, we recently performed single-cell RNA-sequencing 
(RNA-seq) of the developing midbrain and identified multiple cell types, including three different 
types of molecularly-diverse radial glia (Rgl1-3) with distinct temporal gene expression patterns 
and spatial distribution (La Manno et al, 2016). This finding has thus raised several important 
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questions such as: Which of these three radial glia cell types are capable of undergoing 
neurogenesis in the developing VM? Do they also contribute to neurogenesis with cell extrinsic 
factors? How are cell intrinsic and extrinsic factors spatially and temporally integrated? What is the 
cellular microenvironment or niche in which mDA neurogenesis takes place?  
In order to address these questions, we used single cell and bulk RNA-sequencing as well as 
systems biology methodologies to gain further understanding of the cellular and molecular 
components of the mDA neurogenic niche. Our study identifies Rgl1-3 as the main cell types 
contributing signals and cells to mDA neurogenesis. However, each cell type contributed in a 
different way. While Rgl1 was identified as the neurogenic radial glia cell type, Rgl3 was the main 
contributor to cell extrinsic factors in the mDA neurogenic niche, including morphogens, growth 
factors and ECM. Our work thus provides the first unbiased and integrated analysis of the major 
molecular processes taking place in the mDA neurogenic niche. We also found how the expression 
of transcription factors, as well as signaling and ECM components, are controlled over time and in 
defined cell types forming the mDA neurogenic niche. We conclude that efforts aiming at 
recapitulating mDA neuron development in stem cells, either for cell replacement or for in vitro 
disease modeling, should thus focus on the generation of Rgl1 and Rgl3, the two main pillars of 
mDA neurogenesis. 
 
RESULTS 
Transcriptomic analysis of the embryonic ventral midbrain  
In order to obtain a genome-wide view of the niche occupied by midbrain progenitor cells 
during mDA neurogenesis, we performed bulk RNA-seq of the mouse VM and surrounding tissues 
from embryonic day (E)11.5 to E14.5, the period at which mDA neurogenesis takes place (Arenas 
et al, 2015). We obtained transcriptomic profiles from five different regions of the neural tube of 
TH-GFP mouse embryos (Matsushita et al, 2002): the VM, the ventral hindbrain (HB), ventral 
forebrain (FB), dorsal midbrain (DM) and alar plate (L) (Fig. 1A). Specific anatomical and 
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temporal gene expression patterns were identified in all samples (Fig. 1B). A pair-wise correlation 
comparing all the VM samples revealed that E11.5 was the most divergent stage (Fig. 1C). 
Furthermore, principal component analysis (PCA) confirmed the similarity between E12.5 and 
E13.5 (Fig. 1D, Fig. EV1A). Multiple differentially expressed genes (DEG) were identified in the 
VM, compared to the other dissected brain regions (Table EV1). The VM transcriptome was further 
analyzed by weighted gene co-expression network analysis. Eight gene modules were identified and 
found to correlate with distinct expression patterns that describe the changes in transcriptome over 
time (Fig. EV1B-D, details in Table EV2). These modules can be summarized in three general 
developmental patterns. The first pattern (Fig. 1E, three modules in EV1B), consists of genes whose 
expression is increased over time, such as Slc6a3 (DAT, dopamine transporter), a marker of mDA 
neuron maturation (Fauchey et al, 2000). Gene ontology (GO) analysis of this module showed 
enrichment in processes related to neuronal development and maturation, peaking at E14.5 (Fig. 
EV1F). The second pattern consists of genes whose expression peaks at middle time points E12.5-
13.5 (Fig. 1F, two modules in EV1D), such as Ncor2, which represses the differentiation of 
neuronal precursors (Jepsen et al, 2007). GO analysis showed enrichment of genes involved in 
tissue growth and developmental processes (Fig. EV1E). Lastly, we identified a third pattern with 
decreasing gene expression during development, from E11.5 (Fig. 1G, three modules in EV1C). 
This included genes such as Notch3 and Hes5, a ligand and an effector of the Notch signaling 
pathway, respectively (Louvi & Artavanis-Tsakonas, 2006). GO analysis showed enrichment in 
processes that describe cell proliferation (Fig. EV1G). These analyses thus provided both a detailed 
molecular insight and a general overview of the biological processes taking place in the developing 
VM during mDA neurogenesis, in which there is a shift from proliferation to progressive neuronal 
maturation and repression of progenitor pathways and functions. 
 
The dopaminergic module: A network that defines the midbrain dopaminergic neuron niche  
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To identify molecular processes that specifically occur during VM and mDA neurons, we 
performed a second unbiased weighted gene co-expression network analysis of the transcriptomes, 
but this time including both the VM and neighboring regions. This analysis generated 13 modules 
(or networks) of co-expressed genes, one being the “light green” module (Fig. EV2A) that had the 
most enriched DEG in the VM from E11.5 to E14.5 (Fig. EV2B and Table 1). Further analysis 
revealed that the top 5% of the interactions (1235 out of 24506) involved 181 genes (out of 374), 
which were enough to separate the VM samples at all the stages analyzed, as assessed by PCA (Fig. 
EV2C). This refined module contained many known genes expressed in the mDA lineage (Foxa1, 
Shh, Wnt5a, Th, Ddc, Snca, etc) and was thus designated as the mDA module. This module was 
represented as an undirected co-expression network (Fig. 2A), in which the color of the node 
indicates changes in gene expression (RPKM) over time and the lines linking them represent the 
pair-wise correlation of the linked genes (Langfelder & Horvath, 2008). GO analysis of the mDA 
module provided us with an overview of the biological processes in which these genes participate. 
These included relatively well-studied processes in mDA neuron development, such as dopamine 
biosynthetic process (p-value: 4.19e-9), morphogenesis of epithelium (p-value: 2.85e-5) or neural 
tube development (p-value: 1.91e-3); but also less well studied processes such extracellular matrix 
(p-value: 2.17e-7) or extracellular matrix component (p-value: 8.04e-3), amongst others (Fig. 
EV2D). These results indicate that the ECM is likely to play a more significant role than previously 
anticipated in mDA neuron development. 
In order to identify the cell types contributing to the mDA module by gene expression, we 
used a single-cell RNA-seq analysis of the VM that recently allowed us to identify the twenty-six 
cell types present in the mouse VM during mDA neurogenesis (La Manno et al, 2016). This dataset 
was used to perform a cell type deconvolution of our mDA network, assigning cell type/s to the 
identified expression profiles in the mDA network (Fig. EV3A). 97% of the genes in the network 
(176 of 181 genes) were assigned to at least one cell type. Most of the genes (51.2%) were 
contributed by only four cell types present in the VZ: three types of radial glia like cells (Rgl 1-3) 
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and ependymal cells (Fig. 2B, C). Sixteen additional cell types expressed the remaining 48.8% of 
the gene on the mDA network, while the remaining six other cell types did not contribute to this 
network. Notably, the four VZ cell types were the main contributors to the formation of the ECM 
(p-value: 7.72e-26) and its regulation (p-value: 2.88e-15), according to the gene sets defined in the 
Matrisome project (http://matrisomeproject.mit.edu/) (Naba et al, 2012). GO enrichment analysis 
confirmed that the main contribution of the four VZ cells types was in genes of ECM components, 
neural projections as well as in Shh and FGF signaling pathways (Fig. 2D). These results thus 
identify Rgl and ependymal cells as important contributors to the expression of ECM and critical 
signaling factors controlling mDA neuron development. 
We next examined the specific contribution of the most abundant cell types in the mDA 
niche during neurogenesis, that is, radial glia, but not ependymal cells, which emerge later. Radial 
glia has been previously identified as a neurogenic cell in the mDA lineage (Bonilla et al, 2008) and 
as the source of multiple signaling molecules in the midbrain floor plate (Arenas et al, 2015). We 
thus decided to compare the transcriptome profiles of individual radial glia cell types, Rgl1-3, by 
gene set enrichment analysis (Subramanian et al, 2005) in order to explore whether distinct radial 
glia cell types may be poised to serve distinct functions. Analysis of Rgl1 revealed an enrichment in 
the expression of genes related to cell proliferation, such as M Phase (Normalized Enrichment 
Score (NES): 2.341, q-value <0.001), ribosomal constituents (NES: 2.641, q-value <0.001) and 
cellular biosynthetic process (NES: 1.992, q-value <0.001), which defined Rgl1 as a cell in a highly 
proliferative state. Rgl2, also expressed genes related to proliferation (Mitosis, NES: 1.759, q-value: 
0.04), but additionally expressed genes involved in fatty acid metabolism (NES 1.837, q-value: 
0.01) and cholesterol biosynthesis (NES: 1.893, q-value: 0.006), possibly linking Rgl2 to the 
production of specific midbrain cholesterol metabolites controlling mDA neurogenesis 
(Theofilopoulos et al, 2013). The last radial glia, Rgl3, was not enriched for proliferation genes, but 
rather in ECM core components (NES 2.029, q-value <0.001) and ECM regulators (NES 2.363, q-
value <0.001) as well as signaling pathways (Glypican 1 Pathway, NES: 1.840, q-value: 0.02, 
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Netrin 1 signaling, NES: 1.809, q-value: 0.04). These results suggested a high degree of 
specialization of radial glia and lead us to examine in further detail their contribution to the mDA 
niche with regards to secreted signaling molecules, such as morphogens and growth factors as well 
as ECM.   
 
The extracellular matrix in the ventral midbrain 
In order to further delve into the possible role of the ECM, we decided to identify the VM 
cell types responsible for the expression of genes coding for critical components of the ECM, 
regardless of their contribution to the mDA module. In order to rank the cell type contribution to the 
ECM, we developed a score based on the number of genes being expressed and their levels of 
expression (see methods), taking in account both core ECM components and ECM regulators, as 
defined by the Matrisome gene sets (Hynes & Naba, 2012; Naba et al, 2012). Six cell types (Rgl2-
3, ependymal cells, endothelial, pericytes and microglia) were above a threshold set at 99.9% 
quantile of the mean ECM score (Fig. 3A). These cell types contributed to 82.8% of the total 
number of mRNA molecules of ECM core components (Fig. EV4A), and to 88.2% of ECM 
regulators in the VM (Fig. EV4B). Genes coding for core ECM components (Fig. 3B, EV4C) or 
ECM modifiers (Fig. 3C, EV4D) that were significantly expressed above baseline are shown in a 
color scale proportional to mRNA molecules for each cell type. Our results show that Rgl3, 
endothelial cells and pericytes were the main contributors to ECM core transcripts in the VM (Fig. 
3A). While these 3 cell types shared some of the transcripts (Sparc and Sparccl1), each cell type 
expressed specific transcripts, such as vitronectin, colagen4a1/2 and agrin in endothelia and 
pericytes or netrin1, decorin and spondin1 in Rgl3 (Fig. 3B). The latter finding is particularly 
interesting as we identified Rgl3 as a key component of the mDA neurogenic niche (Fig. 2) and its 
products, Netrin1 and Decorin are known to regulate axonal development in mDA neurons 
(Kastenhuber et al, 2009) and midbrain neurogenesis (Long et al, 2016), respectively. On the other 
hand, we found that microglia is the main cell type involved in ECM regulation (Fig. 3D), in 
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particular, by expressing multiple types of cathepsin proteases (Fig. 3C), which likely contribute to 
remodel the ECM and allow them to migrate through the brain parenchyma (Chapman et al, 1997). 
Finally, from a temporal perspective, we found that Rgl1 and pericytes are more abundant during 
early neurogenesis (E11.5-12.5) while Rgl2-3 predominates during later stage (E14.5-E15.5) and 
ependymal cells subsequently after that at E18.5 (Fig. 3E). Adjusting the scores to the relative 
abundance of cell types at every stage confirmed the importance of the six cell types above and  
indicated an additional contribution of immature DA neurons (DA0) and Neuronal progenitors 
(NProg) at E11.5-E12.5 (Fig. S5 A-F). In summary, our results suggest a quantitatively important 
and constant contribution to the ECM by non midbrain-specific cell types, such as endothelial cells 
pericytes and microglia, suggesting a generic role of these cells.  Instead, we found a midbrain- and 
stage-specific early contribution of NProg and Rgl1, and a late one by Rgl3.  
 
Signaling pathways in the ventral midbrain 
Our analysis of the mDA module in addition of suggesting an important contribution of 
radial glia to the ECM, also identified the cell types expressing signaling pathway components 
known to participate in mDA neuron development (Fig. 2B-D). To determine the possible 
directionality of the developmental signaling pathways, we curated a gene set of ligands and their 
corresponding receptors (see methods, Table EV3) for known signaling pathways and used that 
gene set to identify the cell types expressing ligands and their receptors in the VM. As in the case of 
the ECM, we examined the involvement of a cell type in signaling calculating a receptor score and a 
ligand score (see methods). This analysis identified seven cell types (Rgl1-3, ependymal cells, 
endothelial, pericytes and microglia) as the main contributors to signaling (Fig. 4A), covering 
multiple ligands (Fig. 4B) and receptor families (Fig. 4C), several of which are known for their role 
in embryonic midbrain development (Arenas et al, 2015; Smidt & Burbach, 2007). Notably, Rgl3 
and pericytes showed the highest score for combined number and levels of ligands and receptors 
(Fig. 4A), which indicates that Rgl3 and pericytes are the main signaling centers in the VM. These 
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cells offer the possibility of signaling in an autocrine/paracrine manner and of a cross-talk between 
the neural tissue and the vasculature, whose function and significance for mDA neuron development 
remains to be determined. On the other hand, Rgl1-2 expressed more receptors than ligands (Fig. 
4A), which make them the main candidates to respond to and execute different aspects of VM and 
mDA neuron development.  
As with the ECM score, we adjusted the signaling score to cell type abundance. This 
analysis suggests an early role of mRgl1 and progenitor cells at early stages (Fig. S5 G-I), and a late 
role of generic cell types such as endothelial cells and pericytes, as well as midbrain-specific cell 
types, such as mRgl2 and mRgl3 (Fig. S5 J-L). 
Wnt signaling was represented with the highest number of types of ligands and receptors 
(Fig. 4B-C), underlining the prevalence of this pathway and its importance in mDA neuron 
development (Arenas, 2014). Interestingly, our analysis predicts novel candidate cell-to-cell 
signaling events with single-cell resolution (Fig. 4B-C). For instance, we found evidence for 
autocrine loops in multiple cell types, for nearly all pathways examined: Wnt, Notch, Hedgehog, 
BMP, VEGF, FGF, semaphorins and ephrin in Rgl1-3; CNTF in ependymal cells; TNF in microglia, 
IGF and PDGF in pericytes, and TGF in endothelial cells. No evidence for Slit-Robo and 
endothelin autocrine signaling was found, but rather for possible directional paracrine signaling 
from Rgl3 to endothelial cells (Slit-Robo) or from endothelial cells and microglia to Rgl1-3, 
ependymal and pericytes (endothelin) (Fig. 4B, C). Combined, our findings identify radial glia cells, 
in particular Rgl3, as the midbrain-specific cell type that expresses the most complete combination 
of ECM components and ligands for signaling pathways in midbrain development.  
 
Transcriptional networks in Rgl2 and Rgl3. 
We previously identified floor plate radial glial cells as mDA progenitors (Bonilla et al., 
2008). However, our recent identification of three different types of radial glial cells in the ventral 
midbrain (La Manno et al., 2016) raised the question of which of the three identified radial glia cell 
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types is the mDA progenitor that undergoes mDA neurogenesis. We thus decided to examine the 
transcription factors expressed in each radial glia cell type using curated databases with identified 
target genes (Janky et al, 2014). Transcription factors in the database were filters to include only 
those expressed by Rgl1-3, and then we clustered them according to shared target genes (Fig. 5A, 
EV6A-B). We next investigated which of the possible transcription factor combinations can best 
explain the transcriptional profile of Rgl1-3 (Fig. 5B). Analysis of the statistical significance of the 
multiple combinations of transcription factors that up-regulate target genes in Rgl1-3 was 
performed using the Fast Westfall-Young (FWY) permutation test for multiple testing correction 
(Terada et al, 2013b). This procedure also prunes for non-significant combinations (Tarone, 1990), 
transforming the combinatorial analysis into a tractable problem. The specificity of the transcription 
factor combination analysis was confirmed by performing a control FWY analysis of transcription 
factors randomly selected from MSigDB while maintaining the transcriptional profile of each cell 
type. Random selections of transcription factors in Rgl1-3, resulted in much fewer significant 
combinations than obtained with the transcription factors expressed in each cell (Fig. EV6C). Thus, 
our results show that it is possible to obtain insights of the transcriptional networks responsible for 
the transcriptome of a cell type by integrating information about transcription factor binding sites 
and individual cell type transcriptomes. 
Analysis of Rgl2 identified two large transcription factor clusters composed by Sox and 
proneural basic helix-loop-helix (bHLH) transcription factors (Fig. EV6A). We next investigated by 
which of the possible transcription factor combinations can best explain the transcriptional profile 
of Rgl2. However, FWY analysis showed that the only significant combination of transcription 
factors in Rgl2 was that formed by PAX6 and TCF7L1 (p-value=0.025), which has been reported to 
maintain neural progenitors in undifferentiated state (Kuwahara et al, 2014). Analysis of the target 
genes for these two transcription factors reveled enrichment of GO terms associated to development 
of the forebrain (p-value: 3.12e-45), hindbrain (p-value: 7.88e-8) and midbrain (p-value: 5.89e-5), 
suggesting a generic role in maintenance of neural progenitors. Moreover, Rgl2 cells and PAX6 
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expression are found in the basal plate of the midbrain, a compartment that does not give rise to 
mDA neurons but is rather involved in glial cell development (La Manno et al, 2016). 
Examination of Rgl3 also identified two large clusters formed by Sox and bHLH genes (Fig. 
EV6B). FWY analysis of Rgl3 revealed 15 enriched transcription factor combinations, which 
formed a network centered on TEAD1, a component of the hippo pathway (Harvey & Hariharan, 
2012), as well as RFX4, PDLIM5 and SOX13 (Fig. EV6D-E). Analysis of the targets genes of these 
transcription factors, identified the IGF and Wnt signaling pathways, followed by the regulation 
ECM components (Fig. EV6F), which again underlines a role of Rgl3 in the formation of the mDA 
niche.  
 
Identification of a transcriptional network in Rgl1 involved in mDA neurogenesis. 
We next analyzed Rgl1, the radial glia that appears the earliest in the developing VM (Fig. 
3E) as well as the one expressing less ECM (Fig. 3A) and more receptors than ligands for 
developmental pathways (Fig. 4A). As it was the case for Rgl1 and Rgl3, two large Sox and bHLH 
transcription factor clusters with common target genes were identified (Fig. 5A). However, our 
FWY analysis revealed that a total of 25 transcription factors generate 419 significant combinations 
(Table EV4). We used a network to represent the combinations of transcription factors. A pairwise 
interaction score was calculated for all significant transcription factor combinations, based on the 
frequency and p-value (Fig. 5C). The mean number of transcription factors per combination was 
5.465 (Fig. 5D) and the five most common transcription factors were ARNTL, E2F3, ASCL1, SOX5 
and TCF4 (Fig. 5E). The transcription factors E2F5 and E2F3, two cell cycle regulators (Chen et al, 
2009; Trimarchi & Lees, 2002), showed the highest number of interaction partners (node degree, 
Fig. 5F), but these interactions were less frequent and with higher p-values. When node degrees 
were weighted for interaction score, ARNTL was identified as the central gene in the network (Fig. 
5F), followed by E2F3, ASCL1, E2F5, TCF3, TCF4, TCF12, SOX2, SOX5 and SREBF1. These 
results indicate that components of the bHLH neurogenic cluster, such as ARNTL, ASCL1, TCF3, 
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TCF4 and TCF12, explain most aspects of the transcriptional state of Rgl1. Moreover, some of the 
genes in this cluster have been previously found to regulate mDA neurogenesis, such as Ascl1, 
which works in concert with Neurog2 (Kele et al, 2006); or TCF3 and 4, that interact with active  -
catenin to control mDA neurogenesis (Arenas, 2014); or SREBF1, a direct target of the nuclear 
receptors Nr1h2 and Nr1h3 (Schultz et al, 2000), that are required and sufficient for mDA 
neurogenesis (Sacchetti et al, 2009; Theofilopoulos et al, 2013).   
Target genes of the transcription factors in this network were analyzed for enrichment using 
the curated gene sets of the molecular signature database repository (MSigDB, (Subramanian et al, 
2005)). We found that the main functions controlled by this network were the regulation of cell 
cycle as well as Wnt and Notch signaling (Fig. EV6G), all of which are fundamental for mDA 
neurogenesis (Louvi & Artavanis-Tsakonas, 2006; Arenas et al, 2015). Analysis of putative target 
genes of this network included Wnt signaling components such as DVL2, CTNNB1, GSK3B and 
TCF12 (Fig. 5G) (Inestrosa & Arenas, 2010; Willert & Jones, 2006; Neuman et al, 1993). FOXA1, 
involved in Shh signaling and mDA neuron development (Hynes et al, 1995), as well as 
components of other signaling pathways such as IGF1R (Quesada et al, 2007) and BMP7 
(Brederlau et al, 2002). Genes involved in neurogenesis, such as NEUROD1 (Cho & Tsai, 2004), 
HDAC2 (Jawerka et al, 2010) and TCF12 (Uittenbogaard & Chiaramello, 2002). As well as the 
transcriptions factors required for mDA neuron development, such as NFE2L1 (Villaescusa et al, 
2016) and the nuclear receptor NR4A2 (Zetterström et al, 1997), as well as markers of mature mDA 
neurons, TH and ALDH1A1 (Arenas et al, 2015), were also found. Thus our results indicate that a 
transcriptional network mainly formed by ARNTL, TCFs (3, 4 and 12), ASCL1, SOXs (2 and 5) and 
SREBF1 can set in motion a transcriptional program allowing them to control cell cycle exit and 
neurogenesis, respond to Wnt and Shh signaling and differentiate into postmitotic neuroblasts and 
mDA neurons. 
Combined, our analysis of transcription factor networks and their target genes suggest that 
each Rgl cell type contribute to diverse aspects of VM and mDA neuron development. While Rgl2 
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expresses transcription factors known to control progenitor maintenance, Rgl3 expresses niche 
signals. Notably, the only radial glia cell type found to expresses a significant combination of 
transcription factors known to regulate mDA neurogenesis was Rgl1, suggesting that this is the cell 
type previously found to undergo mDA neurogenesis in the VM (Bonilla et al., 2008).  
 
ARNTL is required for mDA neurogenesis 
Our analysis of Rgl1 identified ARNTL as the central node and the most predominant 
transcription factor in a network that explains the transcriptional profile of Rgl1. ARNTL is known 
to promote neurogenesis, control cell cycle exit and regulate circadian rhythm (Bouchard-Cannon et 
al, 2013; Kimiwada et al, 2009; Malik et al, 2015). However, it is at present unknown whether it 
plays any role in VM development or mDA neurogenesis. We thus decided to examine whether 
ARNTL is both sufficient and required for mDA neuron development. For this purpose, we first 
examined the presence of ARNTL in the developing midbrain and found that it is present in Sox2+ 
cells in the developing midbrain floor plate at E13.5 (Fig S7A). To test its functionality we then 
took advantage of a human long-term neuroepithelial stem (hLT-NES) cell line derived from human 
embryos (Sai2, Tailor et al, 2013), and performed ARNTL gain and loss of function experiments 
(Fig. 6A,B, S7B) during mDA neuron differentiation (Villaescusa et al, 2016). As previously 
reported, hLT-NES cells acquired a midbrain floor plate phenotype, assessed by the presence of 
both FOXA2 and LMX1A (Fig. 6C) and immunoreactivity for DA markers such as TH and NR4A2 
at day 8 of differentiation (Fig. 6D).  
For gain of function of experiments, proliferating hLT-NES cells were transduced at day -2 
with a lentivirus carrying a tetracycline-inducible vector (Gossen et al, 1995) encoding for ARNTL, 
or GFP as control. Cells were treated with doxycycline from day-1 to day 1 and given a 4 h pulse of 
EdU before day 0, to mark proliferating cells that undergo mDA neurogenesis and become EdU+ 
and TH+ at day 8 after differentiation (Fig S7B). Analysis of ARNTL levels at day 0 revealed a 75% 
increase in protein levels compared to endogenous levels in GFP-expressing control cells (Fig. 
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S7C). Notably, we found that ARNTL overexpression at this level did not affect the proportion of 
TH+ cells undergoing neurogenesis (double EdU+ and TH+, Fig. S7D, E), but higher levels of 
ARNTL impaired their survival. These results suggested that ARNT overexpression “per se” is 
either not active in this process or that it cannot increase mDA neurogenesis beyond what 
endogenous levels ARNTL already achieve in Lt-NES cells. We thus examined whether endogenous 
ARNTL is required for mDA neurogenesis. 
We next performed loss of function experiments using lentiviral vectors to stably 
knockdown endogenous ARNTL in hLT-NES cells. The resulting cell line, shARNTL-hLT-NES, 
exhibited a dramatic reduction of ARNTL protein levels, compared to a control shRNA (shControl, 
Fig. 6B). As with the gain of function, hLT-NES cells were pulsed with EdU before differentiation, 
to examine neurogenesis. Analysis of cells differentiated for 8 days revealed that the percentage of 
EdU+ and TH+ cells was reduced by 80%, from 14.23 ± 0.04% (mean ± SD) in shControl to 3.79 ± 
0.017% in shARNTL-hLT-NES (Fig. 6E, F). Thus, our results show that endogenous ARNTL is 
required for DA neurogenesis and support the emerging concept that a network of bHLH 
transcription factors controls this process.  
 
DISCUSSION 
In this study, we have gained a broad view of the transcriptional programs operating in the 
VM and at single-cell level during mDA neurogenesis. Our analysis identifies a transcriptional 
program that defines mDA neuron development and Rgl1-3 as the main cell types expressing genes 
that regulate mDA neurogenesis and the mDA niche, providing thus novel insights into midbrain 
development at a single-cell level. Notably, we found that Rgl1 selectively expresses transcription 
factors controlling target genes required for mDA neurogenesis and cell membrane receptors for 
multiple developmental signals. On the other hand, Rgl2 was found to express transcription factors 
responsible progenitor maintenance, receptors for developmental factors and genes involved in lipid 
metabolism. Finally, Rgl3 was found to express transcription factors regulating the formation and 
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maintenance of the mDA niche, as well as multiple ECM components and ligands controlling 
several developmental pathways (Fig. 6). Thus, our study suggests that each of the three radial glia 
cell types (Rgl1-3) contributes to different aspects of mDA neuron development.  
Our analysis of the VM transcriptome identified a mDA module that was mainly contributed 
to by seven cell types: Rgl1-3, ependymal cells, endothelial cells, pericytes and microglia. 
However, the most abundant cells contributing to mDA neurogenesis were Rgl1 (E11.5-E12.5), 
Rgl2 (E13.5-E14.5) and Rgl3 (E15.5). Moreover, two of them, Rgl1 and Rgl3, are present in the 
midbrain floor pate (La Manno et al, 2016), the anatomical compartment that generates mDA 
neurons (Arenas et al, 2015). While both cells contribute to the expression of developmental signals 
that control mDA neurogenesis, we found that Rgl3 is the main contributor to ligands and ECM. We 
also identify Rgl1 as the main cell type expressing receptors for midbrain developmental signals. 
Thus, our data suggest a model in which Rgl1 controls neurogenesis in an autocrine manner from 
E11.5 to E13.5 and Rgl3 in a paracrine fashion from E13.5-E14.5. This switch in neurogenic 
regulation may be of importance for mDA neuron development as substantia nigra mDA neurons 
emerge earlier than those in the ventral tegmental area. We thus examined the expression of ligands 
in early radial glia (Rgl1) versus late radial glia (Rgl3) for pathways whose receptors are expressed 
in Rgl1. While no change in expression was detected for ligands such as Shh, Sema3b, Sema5b, 
Efna4 and Efnb1, a switch was detected from Wnt7a and Wnt7b in Rgl1 to Wnt5a and Wnt5b in 
Rgl3. In addition, other factors were expressed in early Rgl1, such as Jag1, or in late Rgl3, such as 
Sfrp1, Dkk3, Bmp1, Fgf7, Ntn1, Dcn and Spon1. These results suggest that one of the major changes 
taking place in early vs late mDA neuron niche is a switch form early Wnt/-catenin signaling by 
Wnt7a (Fernando et al, 2014) to late Wnt/-catenin-independent signaling by Wnt5a (Andersson et 
al, 2008). This switch was further confirmed by the late action of two pro-differentiation Wnt/-
catenin inhibitors such as Sfrp1 (Kele et al, 2012) and Dkk3 (Fukusumi et al, 2015), reinforcing 
thus a role for Wnt/-catenin-independent signaling at late stages. The necessity of an appropriate 
balance between these two pathways has been recently confirmed by analysis of double Wnt1 and 
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Wnt5a mutant mice (Andersson et al, 2013). Our study thus extends to Wnt5b and Wnt7b the 
spectra of candidate Wnt ligands participating in this complex balance and identifies the precise cell 
types expressing Wnts and their receptors during mDA neuron development.  
We also found that cell types that are not midbrain specific, such as endothelial cells, 
pericytes and microglia, express factors relevant for mDA neurogenesis, such as Wnt5b and Jag1 
(Fig. 4A). Notably, the vasculature is known to be in contact with radial glia cells and their process 
during development, allowing thus for direct or indirect modulation of mDA neurogenesis. We thus 
suggest that these cells can be part of a generic neurogenic niche, that may add on to midbrain-
specific signals derived from radial glia.  
Our bioinformatics analysis of the transcription factor networks in Rgl1-3 also suggest 
individual functions for each radial glia cell type. These range from controlling neurogenesis 
(Rgl1), to progenitor maintenance (Rgl2) and niche formation (Rgl3). Notably, our results suggest 
that the radial glia previously identified to undergo mDA neurogenesis (Bonilla et al, 2008), is 
Rgl1. Indeed, Rgl1 expressed a neurogenic bHLH network formed by Arntl, Ascl1, Tcf3, 4, 12 and 
Srebf1. Previous studies have linked transcription factors such as Ascl1 to mDA neurogenesis, via 
Neurog2 (Kele et al, 2006), or Tcf3/4 regulated by Wnt/-catenin signaling (Arenas, 2014) or Srebf1 
(Schultz et al, 2000) by Nr1h2-3/Lxr (Sacchetti et al, 2009; Theofilopoulos et al, 2013). Moreover, 
the Rgl1 network also includes two members of the Sox family of transcription factors. Sox2, which 
is expressed in floor plate progenitors (Kele et al, 2006; Bonilla et al, 2008) and Sox5, which 
promotes cell cycle exit and differentiation (Martinez-Morales et al, 2010). Notably, this network 
was centered on the clock gene ARNTL, also known as Bmal1, a pioneer transcription factor (Menet 
et al, 2014). ARNTL controls cell cycle entry/exit and neurogenesis (Bouchard-Cannon et al, 2013; 
Malik et al, 2015) and directly regulates the expression of Neurod1 (Kimiwada et al, 2009), a 
proneural transcription factor that initiates neuronal differentiation and migration (Peyton et al, 
1996; Pataskar et al, 2015). ARNTL had not been previously linked to mDA neurogenesis, but based 
on key role predicted by our network analysis, we investigated the role of this transcription factor 
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and found it is required to promote mDA neurogenesis. Thus, our results identify ARNTL as a novel 
factor controlling mDA neuron development, and support the idea that several bHLH transcription 
factors control mDA neurogenesis.   
In sum, our study examined the transcriptome of the developing VM during mDA 
neurogenesis and identifies two radial glia cell types, Rgl1 and Rgl3, as the main components of the 
mDA neurogenic niche. While Rgl1 expresses transcription factors and target genes required for 
mDA neurogenesis, Rgl3 expresses core ECM components and most ligands required to control 
midbrain development and mDA neurogenesis. These cells are part of an extended niche formed by 
a neural component (Rgl1-3 and ependymal cells), a non-neural component (endothelial cells and 
pericytes and microglia). Our results thus uncover the diversity and richness of the molecular 
components of the mDA niche, their cellular origin and their temporal dynamics during mDA 
neurogenesis. Moreover, our results identify novel components of the mDA niche, including a novel 
gene required for mDA neurogenesis, ARNTL, and provide new knowledge that can be applied to 
improve current regenerative medicine approaches for the treatment of Parkinson’s disease.  
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MATERIALS AND METHODS 
Bulk transcriptome determination. Mouse embryos were obtained from TH-GFP animals 
(Matsushita et al, 2002) that were mated overnight, and noon of the day the plug was considered 
E0.5. Embryos were dissected out of the uterine horns at E11.5-E14.5 and placed in ice-cold sterile 
PBS where brain regions were dissected under a stereomicroscope with a UV attachment to detect 
GFP. VM samples corresponded to domains M3 to M7 of the floor and basal plate (Nakatani et al, 
2007). Tissue samples were collected in separate tubes, stored at -80˚C until RNA isolation. Ethical 
approval for mice experimentation was granted by the local ethics committee, Stockholm Norra 
Djurförsöksetiska Nämnd number N326/12 and N158/15.  
Total RNA isolation was performed with RNeasy kit (Qiagen). The RNA integrity and 
concentration was checked using Qubit and 2200 TapeStation (Agilent). Illumina TruSeq libraries 
were prepared using kit and protocols from Illumina. High-throughput sequencing was performed 
on a HiSeq 2000. 
Genes Expression Analysis. Differentially expressed genes (DEG) on each developmental stage 
were identified utilizing Qlucore Omics Explorer v3.1 (Qlucore AB, Lund, Sweden) utilizing t-test 
comparing VM samples versus other regions, with false discovery rate q-value correction (Storey, 
2002). Variance filter of 15% and a threshold for significance of p-value = 0.01 across stages, unless 
otherwise stated. Sample correlation was calculated from log2(RPKM+1) values after variance 
filtering of 12.5%. Single-cell expression data was obtained from La Manno et al. 2016. Significant 
expression is baseline (>99.8% posterior probability). Analyses were made using R (https://www.r-
project.org) and ggplot2 for plots (http://ggplot2.org/). 
Weighted Gene Co-Expression Network Analysis (WGCNA) (Langfelder & Horvath, 2008) was 
performed with the log2(RPKM+1) transformed values, filtered by variance until 10,068 genes 
were selected. The topological overlap matrix was calculated with the variables of a signed 
network, with power of 7. The identification of modules was performed with the “tree” option on a 
minimum module size of 100; modules with correlation higher than 90% were merged. Module 
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enrichment for DEG in VM at all analyzed stages was done with Fisher’s exact test with false 
discovery rate q-value correction (Storey, 2002). A score for the enrichment was calculated as the 
product between the –log10(q-value) and a standardized z-score for DEG per module. Module 
network layout was made using Cytoscape and interactions in the top 5% of adjacency were 
selected for further analysis. Expression changes over time are represented by the color of each 
node, which was calculated as the normalized difference of RPKM between late (E13.5, E14.5) and 
early (E11.5, E12.5) for each gene.  
The identification of VM gene modules with developmental or stage dependent expression 
were identified with WGCNA on the VM samples from E11.5 to E14.5. Further filtering for genes 
not expressed in the VM was performed until 9,061 genes were selected. The topological overlap 
matrix was calculated with the options of a signed network, with power of 17. The identification of 
modules was performed with the “tree” option on a minimum module size of 100 genes, modules 
with correlation higher than 99% were merged. Correlation with samples trait and Student 
asymptotic p-values were calculated as described (Langfelder & Horvath, 2008). Embryonic stage 
(E11.5 to E14.5) was used as sample trait, ordinal values for stage (1 for E11.5, 2 for E12.5 and so 
on), and binary values for middle stages (E12.5, E13.5 as 1). Network layouts and analysis, were 
made using Cytoscape v3.3.0 (Shannon et al, 2003) or Gephi v0.9.1 (Bastian et al, 2009). WGCNA 
were carried out with the R package v1.49 (Langfelder & Horvath, 2008). 
Score for cell types contribution to ECM or signaling. Cell type contribution for ECM or 
signaling were calculated with the data from single cell of mouse VM (La Manno et al, 2016). The 
identified transcripts corresponded to cells found in the floor plate and basal plate of the midbrain, 
domains M3 to M7 (Nakatani et al, 2007). We selected the two components for each analysis. ECM 
was the result of the ECM core genes and ECM regulation gene sets (Naba et al, 2012). For 
signaling, curated ligands and receptors gene sets (Table EV3). 
The score for a gene set is calculated as: 
𝑆𝑔𝑠𝑒𝑡,𝑐𝑡,𝑆𝑡𝑎𝑔𝑒 = 𝛼𝑐𝑡,𝑆𝑡𝑎𝑔𝑒 ∗
∑ 𝑀𝑔,𝑐𝑡𝑔∈𝑔𝑠𝑒𝑡
∑ ∑ 𝑀𝑔,𝑐𝑔∈𝑠𝑒𝑡𝑐∈𝑐𝑡𝑦𝑝𝑒𝑠
+ ∗ 𝛼𝑐𝑡,𝑆𝑡𝑎𝑔𝑒 ∗
∑ 𝑁𝑔,𝑐𝑡𝑔∈𝑔𝑠𝑒𝑡
∑ ∑ 𝑁𝑔,𝑐𝑔∈𝑠𝑒𝑡𝑐∈𝑐𝑡𝑦𝑝𝑒𝑠
 (1) 
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Let 𝑀𝑔,𝑐𝑡 be the Bayesian estimate of the expression level of the gene g in cell type ct and let 𝑁𝑔,𝑐𝑡 
be the value of the indicator vector that is 1 when the gene g is expressed in cell type ct above 
baseline and 0 otherwise. Let 𝛼𝑐𝑡 be the relative sampling ratio of cell type ct in a developmental 
stage, with a value of 1 when the analysis include all the developmental stages. The score is an 
indicator between diversity of genes in a biological function or gene set and the expression levels of 
those genes. A combined score by the sum of both components give us an ECM or signaling scores. 
This simplification of a biological process in a tissue, provide an indicator for a biological processes 
break down by the cell types found in that tissue. The threshold line was set at the percentile 99.9% 
of the bootstrapped distribution of the mean of the combined score with 10e5 replicates.  
Pathway receptor ligand. A list of ligand (159 genes) and receptors or co-receptor (114 genes) 
was curated from the literature, representing 21 signaling pathways. Ligands and receptors were 
grouped in pathways, without assuming specific ligand-receptor pair (Table EV3).  
Network single-cell deconvolution. Using data from La Manno et al., each gene in the network 
was assigned to the cell types that expressed that gene, as identified above baseline (see above and 
(La Manno et al, 2016)). Cell types represented by one gene, or cell types with a final contribution 
less than 1% of the genes were excluded from the network.  
Single-Cell Transcription Factor pattern mining. Transcription factors expressed on each radial 
glia cells were used as input to obtain the target of the human homologous from iRegulon plugin for 
Cytoscape (Janky et al, 2014), retrieving up to 1,000 target genes per transcription factor. Targets of 
transcription factors by cell type detailed on table EV5. Clustering of the transcription factor was 
done by Jaccard index, as an indicator of shared target genes.  
Analysis of enrichment of combinatorial transcription factor target genes were done using 
Fast Westfall-Young (FWY) permutation procedure v1.0.1 (Terada et al, 2013a, 2013b). This is a 
computational efficient procedure for multiple testing correction with higher detection sensitivity 
than commonly used algorithms (Terada et al, 2013b). Upregulated or enriched genes among Rgl 
cells types was scored using the logarithmic difference between the groups (Subramanian et al, 
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2005). Values above 0.5 (or 50% of upregulation) were considered enriched in that cell type. Targets 
of the transcription factors were tested for enrichment in the upregulated genes in the one-tailed 
Fisher test with a significance threshold of 0.05, and tested with 1,000 permutations in the FWY to 
generate a null distribution of randomly permutated datasets (Terada et al, 2013b).  
The resulting significant combinatorial patterns were represented as a network on which the 
edge between a set of transcription factors is quantified by an interaction score. This interaction 
score is calculated for each transcription factor pair as the sum of –log10 (adjusted p-value) for all 
the transcription factor combinations of that pair. Adjusted p-values <0.001 were consider equal to 
0.001 for calculations of interaction score. Controls were performed with randomly selected 
transcription factors from MSigDB C3 database (Subramanian et al, 2005). Selecting the same 
numbers of transcription factors used before for Rgl1-3 respectively. For each cell type, 100 random 
transcription factors combinations were analyzed by FWY maintaining all other setting.  
Gene enrichment. Single-cell Gene Set Enrichment Analysis (GSEA) was done ranking the gene 
by the class difference for the cell type of interest. The analysis was performed on the GSEA 
software v2.2.2 (Subramanian et al, 2005) with the MSigDB genesets v5.0 for canonical pathways 
and GO biological processes (Subramanian et al, 2005). Due to the nature of the single-cell 
transcriptome profiles and molecular counting with unique molecular identifiers (Islam et al, 2014), 
negative enrichment score (ES) on a gene set for a cell type in particular have no meaning. Instead, 
negative ES were interpreted as enrichment on another compared cell type. Analysis of Gene 
Ontology (GO) enrichment were made utilizing the R package ClusterProfiler (Yu et al, 2012) or 
MSigDB (Subramanian et al, 2005) with false discovery rate q-value correction (Storey, 2002). 
Enrichment of the targets of transcription factor (Fig. EV6CF) were analyzed with hypergeometric 
test and with false discovery rate q-value correction (Storey, 2002) over the MSigDB C2 gene sets 
(Subramanian et al, 2005). 
Human neuroepithelial stem cell differentiation.  Sai2 hLT-NES cells were maintained as 
described of hLT-NES cell (Tailor et al, 2013), DA differentiation and lentivirus infection were 
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performed as previously described (Villaescusa et al, 2016). Each experimental condition was 
examined in three separate experiments and duplicate determinations.  
Commercially available ARNTL shRNA lentiviral particles targeted against the human 
transcript were used (sc-38165, Santa Cruz Biotech.) to generate stable cell lines selected with 
puromycin (500 ng/ml first 4 days, maintained with 200 ng/ml). As negative control, lentiviral 
particles against no know human mRNA were used (sc-108080, Santa Cruz Biotech.). Expression 
levels of ARNTL were analyzed by western blot of total cell lysates, with anti-Arntl (1:1000, 
ab93806, Abcam). For loading control, anti-Lamin-B1 was used (1:5000, ab16048, Abcam). 
Differentiation experiments were done with stable shRNA cells with less than 10 passages counted 
from the lentiviral infection.  
 Mouse Arntl cDNA-pcDNA3.1 expression vector (Etchegaray et al, 2003) (kindly donate by 
Professors Steven Reppert and David Weaver, University of Massachusetts Medical School), was 
cloned into the lentiviral backbone Tet-O-FUW-EGFP (Addgene #30130) by blunt-end ligation into 
EcoRI blunted site of the backbone, replacing the EGFP open reading frame. The final plasmid was 
verified by sequencing before usage. Lentiviral production, infection and immunofluorescence were 
performed as previously described (Villaescusa et al, 2016; di Val Cervo et al, 2017). Inducible 
expression of ARNTL was done with doxycycline (Sigma, 50 µg/ml for day -1 and day 0, and 25 
µg/ml for day 1).    
Immunofluorescence was captured with a confocal microscope Zeiss LSM700 with a 10X 
0.45NA objective, at a resolution of 0.3126 µm/pixel. A minimum of nine images per well were 
captured, with two technical replicates per condition in independent biological experiments (N=3 
for LOF experiments, and N=4 for GOF experiments). Quantifications of EdU and DAPI positive 
nuclei were done utilizing Cell Profiler v2.2.0 (Jones et al, 2008). Double positive cell for TH and 
EdU, and total TH cells were counted manually in a condition-blind manner. This was done by 
randomizing each file name with blindanalysis perl script (Salter, 2016). Full images had linear 
levels adjusted for better visualization,  done in Fiji (Schindelin et al, 2012). 
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FIGURE LEGENDS 
Figure 1. Transcriptomic profile of the ventral midbrain.  
(A) Embryonic tissue dissection scheme and regions collected for RNA-seq from TH-GFP embryos 
of stages E11.5, E12.5, E13.5 and E14.5. VM, ventral midbrain. DM, dorsal midbrain. FB, 
forebrain floor plate. HB, hindbrain floor plate. L, alar plate. (B) Heat map representation of high 
variance genes (rows) in dataset of all samples (columns) across all time points. Samples are color 
coded for stage and region. (C) Correlation of VM samples after filtering for variance (12.5%). (D) 
First principal component analysis of VM samples across all time points. Full plot is in Fig. EV1A. 
(E-G) Gene expression patterns in the developing VM as obtained by WGCNA of the VM samples. 
(E) Pattern summarizing gene modules with positive correlation over development (top left) and 
examples of genes: Slc6a3, Ostbp2 and Gria1. (F) Pattern summarizing gene modules correlating at 
E12.5 and E13.5 and examples of genes in these modules: Lrp1, Ncor2 and 6230400d17Rik. (G) 
Pattern summarizing gene modules with negative correlation over development and some examples: 
Hes5, Notch3 and Otx2. Expression is in RPKM. Red lines represent the median expression of each 
module. All modules with significant correlations are shown in Fig. EV1B-D.  
 
Figure 2. The dopaminergic module and its deconvolution at a single-cell level.  
(A) Weighted gene co-expression network analysis of the mDA module, filtered for the top 5% of 
interactions. Color represents changes in levels of gene expression during development. Node size 
is proportional to the mean expression levels of the gene during development. (B) Contribution of 
the different cell types in the VM to the network formed by the dopaminergic module. (C) Diagram 
of VM floor plate with focus on the cell types present in the VZ. (D) GO enrichment terms 
corresponding to genes with the highest contribution to the mDA module. Top, GO for biological 
process. Bottom, GO for cellular components. 
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Figure 3. Analysis of the contribution of individual mouse VM cell types to the composition 
and dynamics of the extracellular matrix.  
(A) Cell type contribution to the ECM as determined by scores for ECM core components and ECM 
regulators. Dotted line represents quantile 99.9% of the bootstrapped mean of the ECM scores. (B) 
Heat map of the expression of core components of the ECM by the most significant cell types. 
Color intensity is proportional to the Bayesian estimate of expression level. Gray scale indicates 
values below significance level. mRgl1-3, radial glia type 1 to 3; mPeri, pericyte; mEndo, 
endothelial cell; mEpend, ependymal cell; mMgl, microglia. (C) Heat map of the expression of 
genes regulating the ECM regulator genes by the most significant cell types, as described as above. 
Color boxes under each gene identify their ontology. (B, C) The horizontal plots represent the total 
number of molecules per cell type. (D) Percentage of genes expressed by each cell type that 
participate in the regulation of the ECM (green) versus core ECM components (purple). (E) 
Relative abundance of cell types at different developmental stages, as sampled by single cell RNA-
sequencing of the VM (La Manno et al, 2016).  
 
Figure 4. Contribution of individual mouse VM cell types to signaling in the mDA niche.  
(A) Plot showing the receptor and ligand scores of the different VM cell types. Color is proportional 
to the signaling score. Dotted line represents quantile 99.9% of the bootstrapped mean of the 
signaling scores. (B) Heat map representation of the expression of receptors in identified VM cell 
types. (C) Heat map representation of the ligands expressed by the most cell types in the VM. Gene 
colored according to their activity; green for activation, red for inhibition and yellow for context-
dependent modulation. (B, C) Color intensity is proportional to the Bayesian estimate of expression 
level. Gray scale indicates values below significance level. mRgl1-3, radial glia type 1 to 3; mPeri, 
pericyte; mEndo, endothelial cell; mEpend, ependymal cell; mMgl, microglia. 
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Figure 5. Combinatorial analysis of the enrichment of transcription factors in Rgl1.  
(A) Clustering of transcription factors expressed in Rgl1 by Jaccard index of shared target genes. A 
bar plot to the right represents the number of targets genes for each transcription factor. (B) 
Diagram of the combinatorial analysis of transcription factors (TF) by their enrichment in common 
targets genes. Left, enriched genes are those regulated by TF1-4 and expressed above threshold. 
Red lines represent upregulated target genes. Several target genes were shared by different TF. 
Right, network representation of TF sharing target genes, analyzed by Fast Westfall-Young (FWY) 
multiple combinatorial transcription factor enrichment. (C) Network representation of FWY 
analysis result of Rgl1. Node color is proportional to node degree and its size is proportional to 
weighted degree. Nodes with high weighted degrees (core nodes) have a black border. Color 
intensity and width of the line connecting two nodes (edge) is proportional to the interaction score 
of the TF pair. (D) Distribution of number of TF involved in significant combinations. (E) 
Frequency distribution of significant TF permutations distributed accordingly to their abundance. 
(F) Plot comparing node degree and weighted node degree of the network. For presentation 
purpose, weighted degree is shown in logarithmic scale. Color intensity and size is proportional to 
weighted degree. (G) Heat map of selected target genes of core transcription factors enriched on 
Rgl1 (red) found in databases.  
 
Figure 6. ARNTL is required for the differentiation of human neuroepithelial stem cell into 
mDA neurons. (A) Representation of the protocol to examine dopaminergic neurogenesis in hLT-
NES cells. (B) Western blot analysis identified the presence of ARNTL in the mouse ventral 
midbrain at E11.5 (left) and in control hLT-NES cells. ARNTL was dramatically reduced by 
shRNAs against ARNTL (right). LAMIN-B1 was used as loading control. (C) The midbrain floor 
plate marker FOXA2 (green) and the DA lineage marker LMX1A (red) are present in hLT-NES at 
day 8 of differentiation. (D) hLT-NES differentiated for 8 days are immunoreactive for the DA 
markers TH (green) and NR4A2 (red). (E) Analysis of neurogenesis in shControl and shARNT 
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hLT-NES cells as identified by the presence of cells double positive (arrows) for TH (green 
cytoplasm) and EdU (red nuclei). (F) Quantification of mDA neurogenesis: TH+ and EdU+ cells 
relative to the total TH+ cells. (p-value = 0.0362, N = 3). Scale bars in C, D and E, 100 µm. 
 
EXTENDED VIEW FIGURE LEGENDS 
Figure EV1. Ventral midbrain developmental genes modules.  
(A) Principal component analysis of VM samples at different developmental times. Insert shows the 
percentage of variance by component. (B) Modules with positive correlation of gene expression 
with development. (C) Modules with negative correlation to development. (D) Modules that 
correlate at E12.5 and E13.5. Correlations and p-values are detailed in each plot. (E-G) GO analysis 
of genes modules correlating at stages E12.5 and E13.5 (E), or with positive (F) or negative (G) 
correlation during development. 
 
Figure EV2. Weighted Gene Co-Expression Network Analysis of all samples.  
(A) Dendrogram of modules obtained from weighted gene co-expression network analysis. The 
mDA module is shown in “light green” and has black border. (B) Heat map of q-value of DEG in 
the mDA module for each developmental stage. Red scale, q-values between 0 and 0.05; black to 
light gray scale, q-values above 0.05. (C) Principal component analysis of the genes corresponding 
to the mDA module “light green”. The genes in the module were sufficient to cluster VM samples 
from the rest of the tissue samples. Color represents tissue and size represents developmental stage. 
(D) GO analysis of genes in the mDA module: Top, biological processes; Bottom, cellular 
components. 
 
Figure EV3. Single-cell network deconvolution. 
(A) Identity matrix of VM cell types and genes expressed in the mDA module. Blue lines represent 
significantly expressed genes in the corresponding cell type, compared to baseline. Red, gene 
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increased; Yellow, maintained; Green, decreased over time. Color scale in figure 2a.  (B) Analysis 
of gene expression levels (RPKM) in the mDA module for each cell type, comparing early 
(E11.5+E12.5) versus late stages (E13.5+E14.5). 
 
Figure EV4. Contribution of different ventral midbrain cell types to the expression of 
extracellular matrix components and modifiers. 
(A-B) Bar plot with the contribution of each cell type to the total number of transcripts for core 
ECM genes (A) and regulatory ECM genes (B). (C) Heat map of ECM core component genes by 
cell type. Color intensity is proportional to the Bayesian estimate of expression level. Gray scale 
indicates values below significance level. Bar plot to the right represents total average of transcripts 
for ECM core components per cell type. (D) Heat map of the genes regulating ECM composition 
per cell type, represented as described above.  
Abbreviations: mMgl, microglia. mRgl1-3, radial glia type 1 to 3. mEndo, endothelial. mPeri, 
pericyte. mEpend, ependymal. mGaba1a, 1b and 2, GABAergic neurons 1a, 1b and 2. mSert, 
serotonergic neurons. mNbL1-2, lateral neuroblasts. mNbML1-5 mediolateral neuroblasts. mRN, 
Red Nucleus. mOMTN oculomotor and trochlear neurons. mNProg, neuronal progenitor. mNbM, 
medial neuroblast. mNbDA DA neuroblast. mDA0-2, DA neurons 1-2. 
 
Figure EV5. Stage dependent contribution of individual mouse VM cell types to signaling and 
ECM score in the mDA niche.  
(A-F) Plots showing the receptor and ligand scores of the different VM cell types considering cell 
type abundance at each developmental stages studied. (G-L) Plots showing the ECM regulator and 
ECM core score considering cell type abundance for each developmental stage. (A, G) E11.5, (B, 
H) E12.5, (C, I) E13.5, (D, J) E14.5, (E, K) E15.5 and (F, L) E18.5. Color intensity is proportional 
to the signaling score. Dotted line at mean plus standard deviation of the mean of the scores.  
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Figure EV6. Combinatorial enrichment of transcription factors on Rgl2 and Rgl3. 
(A) Clustering of transcription factors expressed in Rgl2 by Jaccard index of shared target genes. 
(B) Clustering of transcription factors expressed in Rgl3 by Jaccard index of shared target genes.  
(C) Percentage of FWY significant combinations obtained with random selection of transcription 
factors compared to FWY results of Rgl1-3 transcription profiles. (D) Network representation of 
FWY analysis of Rgl3. Node color and size are proportional to node degree. Nodes with higher 
weighted degrees (core nodes) have a black border. Color intensity and width of the lines 
connecting the nodes are proportional to the interaction score for each transcription factor pair. (E) 
Plot comparing node degree and weighted node degree of the network obtained by FWY analysis of 
Rgl3. Color intensity and size are proportional to the weighted degree. (F) Gene enrichment of 
target genes for core transcription factors in Rgl3. Analysis was performed with MSigDB gene set 
C2 canonical pathways v5.0. (G) Gene enrichment of target genes for core transcription factors in 
Rgl1. Analysis was done with MSigDB gene set C2 canonical pathways v5.0. 
 
Figure EV7. Overexpression of ARNTL in human neuroepithelial stem cells during 
dopaminergic differentiation. 
(A) ARNTL protein (green) is present in SOX2+ cells (red) in the developing mouse VM at E13.5. 
DAPI in blue. Scale bar, 100 µm. Image to the right magnified from box to the left. Full arrow 
heads, double positive SOX2 and ARNTL cells. Empty arrowheads, SOX2 and ARNTL negative 
cells. (B) Protocol for the overexpression of ARNTL in hLT-NES cells. (C) Increased levels of 
ARNTL were detected 24h after doxycycline treatment to LT-NES cells infected with ARNTL-
lentivirus, compared to EGFP as control hLT-NES cells. LAMIN-b1 was used as loading control. 
(D) Representative immunofluorescence images corresponding to control and ARNT transduced 
hLT-NES cells at day 8. Cells having undergone mDA neurogenesis (arrowhead) are identified by 
the incorporation of EdU (red) in TH+ cells (green). Scale bar, 50 µm. (E) Quantification of mDA 
neurogenesis: TH+ and EdU+ cells relative to the total TH+ cells (n.s, non-significant, N = 4). 
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TABLE 
Table 1 
 
Module 
Number VM 
DEG 
Module size q-value 
Enrichment 
Score 
Black 37 551 9.12e-02 -0.55 
Brown 46 856 1.08e-01 -0.14 
Cyan 6 281 9.15e-04 -5.68 
Green 119 2839 9.26e-03 6.10 
Green Yellow 10 423 1.80e-04 -6.35 
Grey 24 519 3.99e-02 -1.53 
Grey60 55 175 1.03e-24 5.80 
Light cyan 18 201 3.26e-02 -2.01 
Light green 191 378 5.88e-136 824.97 
Light yellow 2 100 2.46e-02 -3.28 
Magenta 69 3087 3.56e-17 13.90 
Salmon 54 287 6.10e-14 2.63 
Tan 11 371 2.63e-03 -4.27 
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